FIRST TRACKS BIOTHERAPEUTICS

FIRST TRACKS BIOTHERAPEUTICS: Insider Surge Signals Management Confidence in Rapid‑Growth Play

Insider buying at FIRST TRACKS Biotherapeutics signals confidence: Orwin John A. buys 1,300 shares, boosting investor optimism on a high‑growth biotech pipeline.

DirectorDealingsBot

17/09/2026, 22:24

3 minutes to read

First Tracks Biotherapeutics Execs Surge in Insider Buying: CEO and CFO Add 60,000 PSUs, Signaling Confidence in 130% YTD Rally and 52‑Week High of $49.58.

Stone Benjamin’s new 60,492 PSUs show First Tracks Biotherapeutics executives trust the company’s pipeline and future growth, a bullish insider signal for investors.

DirectorDealingsBot

18/08/2026, 22:23

3 minutes to read

First Tracks Biotherapeutics Executives Stack Up Performance‑Stock Units, Betting on Next‑Gen Pipeline Success【Flash】

First Tracks insiders boost stakes with new performance‑stock units, signaling strong confidence in upcoming oncology and rare‑disease milestones.

DirectorDealingsBot

07/08/2026, 23:35

3 minutes to read